Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1421-1425

  Ciaraldi, Theodore P ^a,b   Morales, Arlene J ^b   Hickman, Matthew G ^a   Odom Ford, Rosanne ^a   Olefsky, Jerrold M ^a   Yen, Samuel S C ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; INSULIN; ISOPRENALINE; PHENYLISOPROPYLADENOSINE;

ADIPOCYTE; ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030957207     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1421     Document Type: Article

References (39)

1. Yen SSC. 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177-207.
2. Dunaif A. 1995 Hyperandrogenic anovulation (PCOS): a unique disorder of insulin notion associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 98(Suppl 1A):33S-39S.
3. Franks SD. Kiddy P, Sharp A, et al. 1991 Obesity and polycystic ovary syndrome. Ann NlY Acad Sci. 626:201-206.
4. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-359.
5. Holte J, Bergh T, Berne C, Berglund L, Lithell H. 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78:1052-1058.
6. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
7. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SSC. 1996 Insulin, somatotrophic and LH axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 81:2854-2864.
8. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 75:577-583.
9. Dunaif A, Segal KR, Shelley DR, et al. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257-1266.
10. Marsden PJ, Murdoch A, Taylor R. 1994 Severe impairment of insulin action in adipocvtes from amenorrheic subjects with polcystic ovary syndrome. Metabolism. 43:1536-1542.
11. Joost HG, Steinfeld H-J. 1982 Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte. Mol Pharmacol. 22:614-618.
12. Ciaraldi TP. 1988 The role of adenosine in insulin action coupling in rat adipocytes. Mol Cell Endocrinol. 60:31-41.
13. Steil GM, Volund A, Kahn SE, Bergman RN. 1993 Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes. 42:250-256.
14. Desbuquois B, Aurbach GD. 1971 Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 33:732-738.
15. Ciaraldi TP, Molina JM, Olefsky JM. 1991 Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport. J Clin Endocrinol Metab. 72:876-882.
16. Rodbell M. 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 239:375-380.
17. Hirsch J, Gallian E. 1968 Methods for the determination of adipose cell size in man and animals. J Lipid Res. 9:110-119.
18. 125I-insulin in adipocytes and IM-9 lymphocytes. J Biol Chem. 257:8667-8673.
19. Whitesell RR, Gliemann J. 1979 Kinetic paramaters of 3-O-methylglucose and glucose in adipocytes. J Biol Chem. 254:5276-5283.
20. McGowan MW, Artiss JD, Strandbergh DR, Zak B. 1983 A peroxidase-coupled method for the colorometric determination of serum triglycerides. Clin Chem. 29:538-543.
21. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. 1995 Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril. 63:329-357.
22. Yki-Jarvinen H, Kubo K, Zawadzki J, et al. 1987 Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM. Am J Physiol. 253:E300-E304.
23. Heseltine L, Webster JM, Taylor R. 1995 Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes. Mol Cell Biochem. 144:147-151.
24. Schwabe U, Schonhofer PS, Ebert R. 1974 Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3′,5′-monophosphate, lipolysis, and glucose oxidation in fat cells. Eur J Physiol. 46:537-545.
25. Green A, Newsholme EA. 1979 Sensitivity of glucose uptake and lipolysis of white adipocytes of the rat to insulin and effects of some metabolites. Biochem J. 180:365-370.
26. Kather H, Scheurer A, Schlierf G. 1987 Antilipolytic action of insulin in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase. Int J Obesity. 11:191-200.
27. Green AG, Milligan G, Dobias SB. 1992 Gi down-regulation as a mechanism for heterologous desensitization in adipocytes. J Biol Chem. 267:3223-3229.
28. Ohisalo JJ. 1981 Effects of adenosine on lipolysis in human subcutaneous fat cells. J Clin Endocrinol Metab. 52:359-363.
29. Ohisalo JJ, Ranta S, Huhtaniemi IT. 1984 Inhibition of adenosine 3′,5′-monophosphate accumulation and lipolysis by adenosine analogs in human subcutaneous adipocytes. J Clin Endocrinol Metab. 58:32-35.
30. 2 in fat-cells of obese volunteers before and during energy restriction. Biochem J. 231:531-535.
31. Vernon RG, Finley E, Taylor E. 1983 Adenosine and the control of lipolysis in rat adipocytes during pregnancy and lactation. Biochem J. 216:121-128.
32. Ohisalo JJ, Stouffer JE. 1979 Adenosine, thyroid status and regulation of lipolysis. Biochem J. 178:249-251.
33. Kaartinen JM, Hreniuk SP, Martin LF, Ranta S, LaNoue KF, Ohisalo JJ. 1991 Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity. Biochem J. 279:17-22.
34. 6-(phenylisopropyl)adenosine on lipolysis in fat cells of massively obese human subjects. Clin Sci. 83:589-592.
35. Koopmans SJ, Sips HCM, Bosman J, Radder JK, Krans HMJ. 1989 Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations. Endocrinology. 125:3044-3050.
36. Olefsky JM, Ciaraldi TP, Kolterman OG. 1985 Mechanisms of insulin resistance in non-insulin-dependent (Type II) diabetes. Am Med J. 79(Suppl 3B):12-22.
37. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z. 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest. 96:801-810.
38. Ciaraldi TP, Hickman M, Morales AJ, Yen SSC, Olefsky JM. 1995 Cellular specificity of insulin resistance in polycystic ovary syndrome. Endocrinology. 136(Suppl 1):179.
39. Legro RS. 1995 The genetics of polycystic ovary syndrome. Am J Med. 98(Suppl 1A):9S-16S.